【摘要】 高血压是发生心血管事件的主要危险因素，患者需长期服用降压药物。长期用药价格较昂贵，在保证降压疗效的同时，需选择成本-效益最优的降压药物进行治疗。本研究对近年来我国不同降压药物治疗原发性高血压患者的药物经济学评价结果进行综述，旨在为患者提供最合理的降压选择。更多还原

【Abstract】 Hypertension is a major risk factor for cardiovascular events, and patients need to take long-term antihypertensive drugs. The price of long-term medication is expensive. While ensuring the antihypertensive effect, it is necessary to select the antihypertensive drugs with the best cost-effectiveness for treatment. This study reviewed the pharmacoeconomic evaluation results of different antihypertensive drugs in the treatment of patients with essential hypertension in China in recent years, aiming to provide the most reasonable antihypertensive choice for patients.更多还原